vs
Ares Commercial Real Estate Corp（ACRE）与太平洋生物科学（ASMB）财务数据对比。点击上方公司名可切换其他公司
Ares Commercial Real Estate Corp的季度营收约是太平洋生物科学的1.2倍（$13.2M vs $10.8M），Ares Commercial Real Estate Corp净利率更高（-29.2% vs -85.2%，领先56.0%），太平洋生物科学同比增速更快（57.6% vs -24.5%）
Ares Commercial Real Estate Corp是隶属于阿瑞斯管理集团的专业金融企业，专注于商业地产领域，提供优先抵押贷款、次级债务、优先股投资等各类定制化融资解决方案，主要服务覆盖美国全境的中型商业地产所有者及运营主体。
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
ACRE vs ASMB — 直观对比
营收规模更大
ACRE
是对方的1.2倍
$10.8M
营收增速更快
ASMB
高出82.1%
-24.5%
净利率更高
ACRE
高出56.0%
-85.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.2M | $10.8M |
| 净利润 | $-3.9M | $-9.2M |
| 毛利率 | — | — |
| 营业利润率 | -29.2% | -100.9% |
| 净利率 | -29.2% | -85.2% |
| 营收同比 | -24.5% | 57.6% |
| 净利润同比 | 63.8% | 4.3% |
| 每股收益（稀释后） | — | $-0.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACREASMB
| Q4 25 | $13.2M | — | ||
| Q3 25 | $14.1M | $10.8M | ||
| Q2 25 | $12.6M | $9.6M | ||
| Q1 25 | $14.9M | $9.4M | ||
| Q4 24 | $17.5M | $7.4M | ||
| Q3 24 | $16.7M | $6.8M | ||
| Q2 24 | $16.8M | $8.5M | ||
| Q1 24 | $18.7M | $5.8M |
净利润ACREASMB
| Q4 25 | $-3.9M | — | ||
| Q3 25 | $4.7M | $-9.2M | ||
| Q2 25 | $-11.0M | $-10.2M | ||
| Q1 25 | $9.3M | $-8.8M | ||
| Q4 24 | $-10.7M | — | ||
| Q3 24 | $-5.9M | $-9.6M | ||
| Q2 24 | $-6.1M | $-11.2M | ||
| Q1 24 | $-12.3M | $-9.1M |
营业利润率ACREASMB
| Q4 25 | -29.2% | — | ||
| Q3 25 | 33.0% | -100.9% | ||
| Q2 25 | -87.8% | -115.2% | ||
| Q1 25 | 64.4% | -105.5% | ||
| Q4 24 | -61.0% | — | ||
| Q3 24 | -35.3% | -160.1% | ||
| Q2 24 | -36.5% | -143.0% | ||
| Q1 24 | -65.9% | -185.5% |
净利率ACREASMB
| Q4 25 | -29.2% | — | ||
| Q3 25 | 33.0% | -85.2% | ||
| Q2 25 | -87.8% | -105.9% | ||
| Q1 25 | 62.5% | -93.6% | ||
| Q4 24 | -60.9% | — | ||
| Q3 24 | -35.3% | -140.4% | ||
| Q2 24 | -36.5% | -130.7% | ||
| Q1 24 | -65.9% | -156.9% |
每股收益（稀释后）ACREASMB
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.72 | ||
| Q2 25 | — | $-1.33 | ||
| Q1 25 | — | $-1.17 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-1.51 | ||
| Q2 24 | — | $-1.98 | ||
| Q1 24 | — | $-1.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $29.3M | $22.5M |
| 总债务越低越好 | $948.2M | — |
| 股东权益账面价值 | $509.6M | $182.7M |
| 总资产 | $1.6B | $240.0M |
| 负债/权益比越低杠杆越低 | 1.86× | — |
8季度趋势，按日历期对齐
现金及短期投资ACREASMB
| Q4 25 | $29.3M | — | ||
| Q3 25 | $84.9M | $22.5M | ||
| Q2 25 | $90.0M | $24.0M | ||
| Q1 25 | $125.5M | $23.4M | ||
| Q4 24 | $63.8M | $38.3M | ||
| Q3 24 | $68.9M | $28.5M | ||
| Q2 24 | $70.6M | $19.2M | ||
| Q1 24 | $99.5M | $18.7M |
总债务ACREASMB
| Q4 25 | $948.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $718.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ACREASMB
| Q4 25 | $509.6M | — | ||
| Q3 25 | $521.0M | $182.7M | ||
| Q2 25 | $523.7M | $18.1M | ||
| Q1 25 | $542.1M | $27.1M | ||
| Q4 24 | $540.1M | $33.4M | ||
| Q3 24 | $563.8M | $26.0M | ||
| Q2 24 | $582.3M | $34.7M | ||
| Q1 24 | $601.1M | $32.6M |
总资产ACREASMB
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.4B | $240.0M | ||
| Q2 25 | $1.4B | $80.8M | ||
| Q1 25 | $1.5B | $99.0M | ||
| Q4 24 | $1.8B | $119.2M | ||
| Q3 24 | $1.9B | $100.3M | ||
| Q2 24 | $2.1B | $115.3M | ||
| Q1 24 | $2.1B | $119.9M |
负债/权益比ACREASMB
| Q4 25 | 1.86× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.33× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.4M | $-15.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-15.2M |
| 自由现金流率自由现金流/营收 | — | -140.7% |
| 资本支出强度资本支出/营收 | — | 0.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACREASMB
| Q4 25 | $21.4M | — | ||
| Q3 25 | $3.8M | $-15.1M | ||
| Q2 25 | $4.9M | $-16.8M | ||
| Q1 25 | $8.0M | $-23.4M | ||
| Q4 24 | $35.5M | $-51.1M | ||
| Q3 24 | $8.4M | $-15.2M | ||
| Q2 24 | $8.7M | $-17.1M | ||
| Q1 24 | $11.4M | $-18.4M |
自由现金流ACREASMB
| Q4 25 | — | — | ||
| Q3 25 | — | $-15.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-17.1M | ||
| Q1 24 | — | $-18.4M |
自由现金流率ACREASMB
| Q4 25 | — | — | ||
| Q3 25 | — | -140.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -695.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -200.6% | ||
| Q1 24 | — | -317.7% |
资本支出强度ACREASMB
| Q4 25 | — | — | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.2% |
现金转化率ACREASMB
| Q4 25 | — | — | ||
| Q3 25 | 0.82× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
